PaulFSiamiMD

PubMed

• 4 citations
  Long-term efficacy and tolerability of abdominal once-yearly histrelin acetate subcutaneous implants in patients with advanced prostate cancer.
  Sean Woolen, Cameron Holzmeyer, Emily Nesbitt, Paul F. Siami> ;Prostate Cancer. 2014 Dec 4
• 3 citations
  Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and ta...
  Byung-Ha Chung, Seung Hwan Lee, Claus G Roehrborn, Paul F Siami, Kim Major-Walker, Timothy H Wilson, Francesco Montorsi> ;International Journal of Urology. 2012 Nov 1
• 10 citations
  Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.
  Norman Zinner, Roger R. Dmochowski, David R. Staskin, Paul Siami, Peter K. Sand, Michael G. Oefelein> ;Neurourology and Urodynamics. 2011 Sep 1
• 73 citations
  Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characterist...
  Claus G. Roehrborn, Jack Barkin, Paul Siami, Andrea Tubaro, Timothy Wilson, Betsy Morrill, R. Paul Gagnier> ;BJU International. 2011 Mar 1
• 59 citations
  Corrigendum to “The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Re...
  Claus G. Roehrborn, Paul Siami, Jack Barkin, Ronaldo Damião, Kim Major-Walker, Indrani Nandy, Betsy Morrill, R. Paul Gagnier, Francesco Montorsi> ;European Urology. 2010 Nov 1
• 71 citations
  Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive bladder.
  Roger R. Dmochowski, Kenneth M. Peters, Jon D. Morrow, Zhonghong Guan, Jason Gong, Franklin Sun, Paul Siami, David R. Staskin> ;Urology. 2010 Jan 1
• 474 citations
  The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the C...
  Claus G. Roehrborn, Paul Siami, Jack Barkin, Ronaldo Damião, Kim Major-Walker, Indrani Nandy, Betsy Morrill, R. Paul Gagnier, Francesco Montorsi> ;European Urology. 2010 Jan 1
• 36 citations
  The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results f...
  Edgardo Becher, Claus G. Roehrborn, Paul Siami, R. P. Gagnier, Timothy Wilson, Francesco Montorsi> ;Prostate Cancer and Prostatic Diseases. 2009 Dec 1
• 38 citations
  Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hy...
  Jack Barkin, Claus G. Roehrborn, Paul Siami, Olivier Haillot, Betsy Morrill, Libby K. Black, Francesco Montorsi> ;BJU International. 2009 Apr 1
• 65 citations
  The Influence of Baseline Parameters on Changes in International Prostate Symptom Score with Dutasteride, Tamsulosin, and Combination Therapy among Men with Symptomati...
  Claus G. Roehrborn, Paul Siami, Jack Barkin, Ronaldo Damião, Edgardo Becher, Bernardino Miñana, Vicenzo Mirone, Ramiro Castro, Timothy Wilson, Francesco Montorsi> ;European Urology. 2009 Feb 1
• 13 citations
  Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-l...
  Steven Swift, Paul Siami, Sergio Forero-Schwanhaeuser> ;Clinical Drug Investigation. 2009 Jan 1
• 14 citations
  Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH
  Byung Ha Chung, Claus G. Roehrborn, Paul Siami, Kim Major-Walker, Betsy Morrill, Timothy Wilson, Francesco Montorsi> ;Prostate Cancer and Prostatic Diseases. 2009 Jan 1
• 41 citations
  Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: Results of a 12-week, multicenter, open-label, flexible-dose study
  Michael B. Chancellor, Norman Zinner, Kristene Whitmore, Kathleen C. Kobashi, Jeffrey A. Snyder, Paul Siami, Mickey M. Karram, Christine Laramée, James P. Capo, Raafat...> ;Clinical Therapeutics. 2008 Oct 1
• 199 citations
  The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia and Prostatic Enlargement: 2-Ye...
  Claus G. Roehrborn, Paul Siami, Jack Barkin, Ronaldo Damião, Kim Major-Walker, Betsy Morrill, Francesco Montorsi> ;The Journal of Urology. 2008 Feb 1
• 54 citations
  Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Av...
  Paul Siami, Claus G. Roehrborn, Jack Barkin, Ronaldo Damião, Marek Wyczółkowski, A. Duggan, Kim Major-Walker, Betsy Morrill> ;Contemporary Clinical Trials. 2007 Nov 1
• 30 citations
  Long‐term treatment with darifenacin for overactive bladder: results of a 2‐year, open‐label extension study
  François Haab, Jacques Corcos, Paul Siami, Karin Glavind, Peter L. Dwyer, Michael Steel, Fernando T. Kawakami, Karine Lheritier, William D. Steers> ;BJU International. 2006 Nov 1
• 44 citations
  Long‐term sustained improvement in symptoms of benign prostatic hyperplasia with the dual 5α‐reductase inhibitor dutasteride: results of 4‐year studies
  Claus G. Roehrborn, Olavi Lukkarinen, Stephen Mark, Paul Siami, Joe W. Ramsdell, Norman Zinner> ;BJU International. 2005 Sep 1
• 40 citations
  A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: the speed of onset of therapeutic assessment trial (STAT).
  Paul Siami, Larry S. Seidman, Daniel Lama> ;Clinical Therapeutics. 2002 Apr 1
• 62 citations
  Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction
  Eugene Dula, William Keating, Paul Siami, Anthony Edmonds, Janet O’neil, Susan M. Buttler> ;Urology. 2000 Jul 1
• 4 citations
  Phase I-II evaluation of intravesical novantrone (mitoxantrone) in superficial bladder cancer.
  Roohollah Sharifi, M. Lee, Michael Clayton, D Lamb, Paul Siami, Michael D. Strub, D Albert, M Sarosdy> ;Anti-Cancer Drugs. 1991 Apr 1
• 3 citations
  'Acute on chronic' effect of depot leuprolide in patients with stage D2 cancer of prostate.
  Roohollah Sharifi, M. Soloway, Michael Clayton, A. Mounzer, Michael D. Strub, Paul Siami, M. Lee> ;Anti-Cancer Drugs. 1990 Oct 1
• 1 citations
  BCG in management of transitional cell carcinoma invasive to prostate
  Paul Siami, Steve Chinn, Michael Clayton, Veronica Ray, Marvin Rubenstein, Patrick Guinan> ;Urology. 1989 Dec 1
• 6 citations
  False positive beta-human chorionic gonadotropin in testicular cancer.
  James L. Mohler, Paul Siami, Robert C. Flanigan> ;Urology. 1987 Sep 1
• 23 citations
  Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.
  Irving H. Gomolin, Paul Siami, Jonathan Reuning-Scherer, Daniel Haverstock, Allen Heyd> ;Journal of the American Geriatrics Society. 2001 Dec 1
• Urethral diverticular carcinoma.
  Clayton, M., Siami, P., Guinan, P.> ;Cancer. 1992 Aug 1
• Join now to see all